9 results
Pharmacologic treatment algorithms by Global Initiative for Chronic Obstructive Lung Disease grade. Highlighted boxes and arrows
Pharmacologic treatment ... algorithms by Global ... indicate preferred treatment ... #Management #Pulmonary ... #COPD #GOLD2017
Prostanoid prescribing and management in Pulmonary Arterial Hypertension (PAH)
Oral Prostanoids:
 - Selexipag
 - Treprostinil
Inhaled Prostanoids
 -
prescribing and management ... in Pulmonary Arterial ... Hypertension (PAH ... #Management #Algorithm ... #treatment #pharmacology
Medical Treatment Algorithm for Chronic Obstructive Pulmonary Disease
Initial medical treatment of chronic obstructive pulmonary disease (COPD)
Algorithm for Chronic ... disease (COPD) ... #COPD #Treatment ... #Algorithm #Management ... SABA #SAMA #ICS #Pharmacology
Low / Intermediate Risk Pulmonary Arterial Hypertension (PAH) Management Algorithm

Dr. John Ryan @JJRyanMD

#Pulmonary #Arterial #Hypertension #PAH
Hypertension (PAH ... ) Management Algorithm ... #Hypertension #PAH ... #Management #Algorithm ... #treatment #pharmacology
COPD Management Algorithm - GOLD 2019 guidelines 

Categorize into COPD GOLD A-D -> Initiate first-line therapy
COPD Management ... Algorithm - GOLD ... #GOLD #GOLD2019 ... #Pulmonary #Algorithm ... #pharmacology
Shock - Differential Diagnosis Framework
 - MAP <65. SBP <90, drop in SBP > 40
 -
Medications, Spinal Cord ... • Obstructive: Pulmonary ... Differential #Diagnosis #criticalcare ... #algorithm #treatment ... #management
It is important to recognize Acute Decompensated Heart Failure (ADHF) as more than just simply a
with presence of pulmonary ... #differential #algorithm ... #management #cardiology ... heartfailure #chf #criticalcare ... icu #clinical #pharmacology
There are similarities and differences between these 3 conditions which all carry treatment implications. Each mimic
which all carry treatment ... breakdown of glycogen stores ... #differential #algorithm ... #management #treatment ... #criticalcare #
Sjogren's Syndrome Overview

Epidemiology:
• F > M: 9:1
• 5-6th Decades (can be any age)

Autoimmune exocrinopathy multisystemic disease
amyloidosis, PAH ... phenomenon (16%) MSK ... Adenocarcinoma Treatment ... lubricants • Pharmacologic ... Rheumatology #Diagnosis #Management